Novartis, Others Can't Stop Generic Tobramycin Suit

Law360, New York (December 21, 2011, 8:37 PM EST) -- An Illinois federal judge on Tuesday denied an attempt by Novartis Pharmaceuticals Corp. and others to dismiss a suit they brought against Akorn Inc. over a patent for cystic fibrosis medication, finding that Akorn should still get a chance to have the patent declared invalid.

Despite a new agreement from plaintiffs Novartis, Seattle Children's Hospital, and Novartis Vaccines and Diagnostics Inc. not to sue Akron for infringement of the patent-in-suit, U.S. District Judge Robert M. Dow Jr., ruled that Akorn can move forward with an attempt...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.